Page last updated: 2024-10-30

lorazepam and Sclerosis

lorazepam has been researched along with Sclerosis in 1 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Sclerosis: A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.

Research Excerpts

ExcerptRelevanceReference
"Kainic acid (KA) is a potent glutamate analog that is used to induce neurodegeneration and model temporal lobe epilepsy (TLE) in rodents."1.46A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam. ( Bauer, S; Costard, L; Kienzler-Norwood, F; Müller, P; Neubert, V; Norwood, BA; Rosenow, F; Sadangi, C, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kienzler-Norwood, F1
Costard, L1
Sadangi, C1
Müller, P1
Neubert, V1
Bauer, S1
Rosenow, F1
Norwood, BA1

Other Studies

1 other study available for lorazepam and Sclerosis

ArticleYear
A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam.
    Epilepsia, 2017, Volume: 58, Issue:2

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalo

2017